Official Title
A Cross-sectional Study on the Positive Rate of Monoclonal Immunoglobulin (M Protein) in the Serum of Patients Seeking Medical Treatment in Tertiary Hospitals Based on a Highly Sensitive Serum M Protein Detection Method.
Brief Summary

By using a highly sensitive serum M protein detection method based on the MALDI-TOF MSplatform, serum monoclonal immunoglobul (M protein) in detection was performed on thevisiting patients to explore the positive rate of serum M protein and its distribution indifferent departments. And exploring the correlation analysis between the relativeconcentration of serum M protein based on the above highly sensitive methods and clinicalindicators.

Detailed Description

Monoclonal gammopathy (MG) is an asymptomatic pre-cancerous clonal proliferation of
plasma cells. The onset of this disease is concealed, usually discovered by chance by
patients who undergo protein electrophoresis to detect monoclonal gamma globulin (M
protein) due to various clinical symptoms and disease evaluations. Due to the insidious
onset of monoclonal immunoglobulin, involving multiple organs, and the non-specific
clinical symptoms, it is more prone to misdiagnosis. This study hypothesized that among
patients who first came to the hospital for treatment, some patients had elevated serum
monoclonal immunoglobulin levels but were not initially diagnosed with hematology
department, but instead sought medical attention from other departments due to other
symptoms. In this study,by using a highly sensitive serum M protein detection method
based on the MALDI-TOF MS platform, serum monoclonal immunoglobul (M protein) in
detection was performed on the visiting patients to explore the positive rate of serum M
protein and its distribution in different departments,and to explore the correlation
analysis between the relative concentration of serum M protein based on the above highly
sensitive methods and clinical indicators.

Recruiting
Multiple Myeloma
M Protein
Eligibility Criteria

Inclusion Criteria:

- Patients attending the outpatient/emergency/inpatient department of Zhujiang
Hospital;

- Age: over 18 years old;

- There are sufficient remaining serum samples and extensive informed consent has been
signed.

Exclusion Criteria:

- Early diagnosis of hematological diseases such as plasma cell or other B lymphocyte
proliferative diseases;

- Improper storage or repeated freeze-thaw of remaining serum samples.

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
China
Locations

Zhujiang Hospital of Southern Medical University
Guangzhou, Guangdong, China

Investigator: Hongwei Zhou, Professor
Contact: 18688489622
hzhou@smu.edu.cn

Contacts

Nianyi Zeng
13928801657 - +86
zengny1@i.smu.edu.cn

Hongwei Zhou, Professor, Study Chair
Zhujiang Hospital

Zhujiang Hospital
NCT Number
Keywords
M protein
MeSH Terms
Multiple Myeloma
Hypersensitivity